Accepted Article DR SWATI RAMTEKE-JADHAV (Orcid ID : 0000-0003-1251-8918) DR MANJUNATH GOROSHI (Orcid ID : 0000-0001-7679-6656) DR TUSHAR BANDGAR (Orcid ID : 0000-0001-7679-6656) Article type : Original Article - Australia, Japan, SE Asia Title: Cabergoline may act as a radioprotective agent in Cushing’s disease Authors: Kunal Thakkar 1 , Anurag Lila 1 , Vijaya Sarathi 2 , Swati Ramteke-Jadhav 1 , Manjunath Goroshi 3 , Saba Samad Memon 1 , Rahul Krishnatry 4 , Tejpal Gupta 4 , Rakesh Jalali 5 , Atul Goel 6 , Abhidha Shah 6 , Shilpa Sankhe 7 , VirendraPatil 1 , Tushar Bandgar 1 , Nalini S Shah 1 1 : Department of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India 2 : Department of Endocrinology, Narayana Medical College, Nellore, India 3 : Department of Endocrinology, JN Medical College and KLES Hospital, Belgaum, India 4 : Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India 5 : Department of Radiation Oncology, Apollo Proton Cancer Centre, Apollo Hospitals, Chennai, India 6 : Department of Neurosurgery, Seth G S Medical College & KEM Hospital, Mumbai, India 7 : Department of Radiology, Seth G S Medical College & KEM Hospital, Mumbai, India Short title: Radioprotection in CD by Cabergoline Key Words: Conventional/Conformal fractionated radiotherapy (CRT), Overnight dexamethasone suppression test (ODST), Cabergoline, Ketoconazole, Remission, Recurrence Corresponding Author: Dr. Swati Ramteke-Jadhav Asst. Professor Department of Endocrinology and Metabolism, This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/CEN.14123 This article is protected by copyright. All rights reserved